SE9701161D0 - New use I - Google Patents
New use IInfo
- Publication number
- SE9701161D0 SE9701161D0 SE9701161A SE9701161A SE9701161D0 SE 9701161 D0 SE9701161 D0 SE 9701161D0 SE 9701161 A SE9701161 A SE 9701161A SE 9701161 A SE9701161 A SE 9701161A SE 9701161 D0 SE9701161 D0 SE 9701161D0
- Authority
- SE
- Sweden
- Prior art keywords
- oxytocin
- new use
- oestrogen
- colic
- navel
- Prior art date
Links
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 abstract 2
- 101800000989 Oxytocin Proteins 0.000 abstract 2
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 abstract 2
- 208000002193 Pain Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 abstract 2
- 229960001723 oxytocin Drugs 0.000 abstract 2
- 208000004998 Abdominal Pain Diseases 0.000 abstract 1
- 208000002881 Colic Diseases 0.000 abstract 1
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9701161A SE9701161D0 (sv) | 1997-03-27 | 1997-03-27 | New use I |
| ES98912861T ES2231975T3 (es) | 1997-03-27 | 1998-03-26 | Utilizacion de substancias con actividad oxitocica para la preparacion de medicamentos destinados para el tratamiento de sindromes dolorosos psicosomaticos. |
| DE69826023T DE69826023T2 (de) | 1997-03-27 | 1998-03-26 | Verwendung von Substanzen mit Oxytocinwirkung zur Herstellung eines Arzneimittels zur Behandlung affektiver Schmerzsyndrome |
| AU67549/98A AU749357B2 (en) | 1997-03-27 | 1998-03-26 | Use of substances having oxytocin activity for preparation of medicaments for the treatment of affective pain syndromes |
| AT98912861T ATE274916T1 (de) | 1997-03-27 | 1998-03-26 | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome |
| EP98912861A EP1027067B1 (fr) | 1997-03-27 | 1998-03-26 | Utilisation de substances a activite oxytocique pour la preparation de medicaments destines au traitement de syndromes douloureux psychosomatiques |
| JP54154698A JP2001527537A (ja) | 1997-03-27 | 1998-03-26 | 情動性の痛み（ａｆｆｅｃｔｉｖｅ ｐａｉｎ）症候群治療用の医薬の製造のためのオキシトシン活性を有する物質の使用 |
| PCT/SE1998/000553 WO1998043660A1 (fr) | 1997-03-27 | 1998-03-26 | Utilisation de substances a activite oxytocique pour la preparation de medicaments destines au traitement de syndromes douloureux psychosomatiques |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9701161A SE9701161D0 (sv) | 1997-03-27 | 1997-03-27 | New use I |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9701161D0 true SE9701161D0 (sv) | 1997-03-27 |
Family
ID=20406368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9701161A SE9701161D0 (sv) | 1997-03-27 | 1997-03-27 | New use I |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1027067B1 (fr) |
| JP (1) | JP2001527537A (fr) |
| AT (1) | ATE274916T1 (fr) |
| AU (1) | AU749357B2 (fr) |
| DE (1) | DE69826023T2 (fr) |
| ES (1) | ES2231975T3 (fr) |
| SE (1) | SE9701161D0 (fr) |
| WO (1) | WO1998043660A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9701162D0 (sv) * | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use II |
| SE9701184D0 (sv) * | 1997-04-01 | 1997-04-01 | Karolinska Innovations Ab | Substanser för att åstadkomma preferens och skapa acceptans |
| ES2174770T1 (es) * | 1999-12-21 | 2002-11-16 | Innogenetics Nv | Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide. |
| SE0100684D0 (sv) * | 2001-02-28 | 2001-02-28 | Kerstin Uvnaes Moberg | New subject-matter |
| DE60333857D1 (de) * | 2002-10-03 | 2010-09-30 | Neuropharmacology Services Llc | Oxytocin zur Behandlung von Autismus und Asperger-Syndrom |
| DE10303672A1 (de) * | 2003-01-24 | 2004-08-05 | Beier, Klaus M., Prof. Dr.med. Dr.phil. | Verwendung eines Neuropeptide und Steroide enthaltenden Gemisches zur Behandlung von Störungen des psychosozialen Erlebens und Verhaltens |
| EP1468690B1 (fr) * | 2003-03-27 | 2008-10-08 | Pantarhei Bioscience B.V. | Utilization d' oestrogenes dans le traitement de la sterilite masculine |
| EP2548550A1 (fr) | 2003-04-10 | 2013-01-23 | Surmodics Pharmaceuticals, Inc. | Microparticules à base d'émulsion |
| ES2625343T3 (es) * | 2003-07-15 | 2017-07-19 | Evonik Corporation | Método para la preparación de formulaciones de liberación controlada |
| CN100588423C (zh) | 2003-07-23 | 2010-02-10 | Pr药品有限公司 | 控释组合物 |
| JO2937B1 (en) | 2004-08-11 | 2016-03-15 | فيرينغ.بي.في | Tight muscles of the peptide vascular tensioner receptor |
| WO2007025286A2 (fr) * | 2005-08-26 | 2007-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methode d'administration de medicaments pour traitement de la douleur trigeminale |
| JP5185830B2 (ja) | 2006-02-10 | 2013-04-17 | フェリング ベスローテン フェンノートシャップ | 新規化合物 |
| EP2175874A2 (fr) | 2007-08-14 | 2010-04-21 | Ferring B.V. | Utilisation d'agonistes peptidiques du récepteur de la vasopressine |
| WO2011027060A2 (fr) | 2009-09-04 | 2011-03-10 | Centre National De La Recherche Scientifique - Crns - | Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique |
| SE536091C2 (sv) | 2011-04-14 | 2013-04-30 | Pep Tonic Medical Ab | Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter |
| PL3242676T3 (pl) | 2015-01-07 | 2024-07-15 | Tonix Pharma Limited | Preparaty oksytocyny zawierające magnez i sposoby ich stosowania |
| NZ787097A (en) | 2016-04-12 | 2025-10-31 | Tonix Pharma Ltd | Magnesium-containing oxytocin formulations and methods of use |
| KR102193195B1 (ko) * | 2018-10-24 | 2020-12-28 | 국립해양생물자원관 | 낙지 옥토프레신 활성 펩타이드 및 이의 용도 |
| WO2020085530A1 (fr) | 2018-10-24 | 2020-04-30 | 국립해양생물자원관 | Peptides ayant une activité d'octopressine de poulpe et utilisation associée |
| WO2021024855A1 (fr) * | 2019-08-02 | 2021-02-11 | 帝人ファーマ株式会社 | Agent thérapeutique ou agent prophylactique destiné à la fibromyalgie |
-
1997
- 1997-03-27 SE SE9701161A patent/SE9701161D0/xx unknown
-
1998
- 1998-03-26 AT AT98912861T patent/ATE274916T1/de active
- 1998-03-26 ES ES98912861T patent/ES2231975T3/es not_active Expired - Lifetime
- 1998-03-26 DE DE69826023T patent/DE69826023T2/de not_active Expired - Lifetime
- 1998-03-26 EP EP98912861A patent/EP1027067B1/fr not_active Expired - Lifetime
- 1998-03-26 WO PCT/SE1998/000553 patent/WO1998043660A1/fr not_active Ceased
- 1998-03-26 AU AU67549/98A patent/AU749357B2/en not_active Ceased
- 1998-03-26 JP JP54154698A patent/JP2001527537A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998043660A1 (fr) | 1998-10-08 |
| JP2001527537A (ja) | 2001-12-25 |
| DE69826023D1 (de) | 2004-10-07 |
| AU6754998A (en) | 1998-10-22 |
| ATE274916T1 (de) | 2004-09-15 |
| EP1027067A1 (fr) | 2000-08-16 |
| ES2231975T3 (es) | 2005-05-16 |
| EP1027067B1 (fr) | 2004-09-01 |
| DE69826023T2 (de) | 2005-09-08 |
| AU749357B2 (en) | 2002-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9701161D0 (sv) | New use I | |
| SE9701162D0 (sv) | New use II | |
| DE59911740D1 (de) | Topisch anwendbare mittel gegen nagelpilzerkrankungen | |
| ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
| DK1411932T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
| ATE186834T1 (de) | Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut | |
| ATE243196T1 (de) | Piperidine und pyrrolidine | |
| ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
| NZ505742A (en) | Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses | |
| DK0832081T3 (da) | Bicykliske-aromatiske forbindelser | |
| MX9805705A (es) | Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| NZ328874A (en) | Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders | |
| ATE275966T1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
| ZA971891B (en) | Use of aryl N-substituted carboxamides directly and as radio- and chemosensitizers for killing tumor and cancer cells and novel compounds for such use | |
| PT1001775E (pt) | Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil | |
| DE69703820D1 (de) | Diaromatische propynyl- oder dienylverbindungen | |
| IT8548055A1 (it) | Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale | |
| ES2175006T3 (es) | N-(pirimidinil)-benzosulfonamidas como medicamentos. | |
| MX9202366A (es) | Nuevas 2-amino-5-ciano-1,4-di hidro piridinas y procedimiento para su fabricacion. | |
| ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
| ES2135065T3 (es) | Derivados de amida y su uso terapeutico. | |
| NO970185L (no) | Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi | |
| DE50010972D1 (de) | UBICHINON Qn ZUR BEHANDLUNG VON MIGRÄNESCHMERZEN | |
| RU94024337A (ru) | Антиметастатическое средство | |
| RU94039553A (ru) | Средство для лечения хронического простатита |